Suchergebnisse - "Hu, Yongzhou"

PubPharm (391)

51

Tripeptide epoxyketone compound constructed by heterocycle and preparation method and use thereof

enthalten in: Europäisches Patentamt | 2018

von HU YONGZHOU | LI JIA | LIU TAO | +6

52

Discovery of a novel series of α-terpineol derivatives as promising anti-asthmatic agents : Their design, synthesis, and biological evaluation

enthalten in: European journal of medicinal chemistry | 2018

von Zhu, W. | Liu, X. | Wang, Y. | +2

53

An ultrasensitive fluorogenic probe for revealing the role of glutathione in chemotherapy resistance

enthalten in: Chemical science | 2017

von Jiang, Y. | Cheng, J. | Yang, C. | +5

54

A fluorogenic probe for imaging protein S-nitrosylation in live cells

enthalten in: Biosensors & bioelectronics | 2017

von Shao, S. | Chen, B. | Cheng, J. | +7

55

Discovery of a series of N-(5-(quinolin-6-yl)pyridin-3-yl)benzenesulfonamides as PI3K/mTOR dual inhibitors

enthalten in: European journal of medicinal chemistry | 2017

von Zhang, J. | Lv, X. | Ma, X. | +1

56

TRIPEPTIDE EPOXYKETONE COMPOUND CONSTRUCTED BY HETEROCYCLE AND PREPARATION METHOD AND USE THEREOF

enthalten in: Europäisches Patentamt | 2017

von HU YONGZHOU | LI JIA | LIU TAO | +6

57

Discovery of a series of N-(5-(quinolin-6-yl)pyridin-3-yl)benzenesulfonamides as PI3K/mTOR dual inhibitors

enthalten in: European journal of medicinal chemistry | 2017

von Zhang, J. | Lv, X. | Ma, X. | +1

58

An ultrasensitive fluorogenic probe for revealing the role of glutathione in chemotherapy resistanceElectronic supplementary information (ESI) available: Synthesis of probes and their characterization, biological methods, supplementary figures. See DOI: 10.1039/c7sc03338a

enthalten in: Chem.Sci. | 2017

von Jiang, Y. | Cheng, J. | Yang, C. | +5

59

Design, Synthesis and Evaluation of Indene Derivatives as Retinoic Acid Receptor α Agonists

enthalten in: Molecules (Basel, Switzerland) | 2016

von Guan, X. | Luo, P. | He, Q. | +2

60

Discovery of 4-chloro-3-(5-(pyridin-3-yl)-1,2,4-oxadiazole-3-yl)benzamides as novel RET kinase inhibitors

enthalten in: Bioorganic & medicinal chemistry letters | 2016

von Han, M. | Li, S. | Ai, J. | +4